相似文献
1
Optimal use of methotrexate: the advantages of tight control.
Ann Rheum Dis. 2007 Nov;66(11):1409-10. doi: 10.1136/ard.2007.076463.
2
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
Ann Intern Med. 2012 Mar 6;156(5):329-39. doi: 10.7326/0003-4819-156-5-201203060-00004.
3
Long-term treatment with every-other-week methotrexate in rheumatoid arthritis patients with sustained disease improvement: comment on the article by Kremer et al.
Arthritis Rheum. 1995 Dec;38(12):1865-6. doi: 10.1002/art.1780381229.
4
Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
Rheumatology (Oxford). 2006 May;45(5):497-9. doi: 10.1093/rheumatology/kel014. Epub 2006 Mar 14.
5
What dose of folic acid to use with methotrexate in rheumatoid arthritis?
Drug Ther Bull. 2021 Jul;59(7):103-106. doi: 10.1136/dtb.2020.000061.
6
[Treatment of chronic polyarthritis with methotrexate 1994--a review].
Z Rheumatol. 1994 Jul-Aug;53(4):199-229.
7
Key findings from studies of methotrexate tapering and withdrawal in rheumatoid arthritis.
Expert Rev Clin Pharmacol. 2015;8(6):751-60. doi: 10.1586/17512433.2015.1077698. Epub 2015 Aug 13.
8
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.
Rheumatol Int. 2018 Dec;38(12):2225-2231. doi: 10.1007/s00296-018-4173-3. Epub 2018 Oct 20.
9
Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
Rheumatol Int. 2017 Sep;37(9):1469-1479. doi: 10.1007/s00296-017-3749-7. Epub 2017 Jun 9.
10
A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry.
Ann Rheum Dis. 2012 Jun;71(6):845-50. doi: 10.1136/annrheumdis-2011-200274. Epub 2011 Dec 30.
引用本文的文献
1
TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol.
Trials. 2020 Oct 16;21(1):862. doi: 10.1186/s13063-020-04731-2.
2
Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products.
Evid Based Complement Alternat Med. 2020 Apr 28;2020:7531967. doi: 10.1155/2020/7531967. eCollection 2020.
3
CDK7 inhibition suppresses rheumatoid arthritis inflammation via blockage of NF-κB activation and IL-1β/IL-6 secretion.
J Cell Mol Med. 2018 Feb;22(2):1292-1301. doi: 10.1111/jcmm.13414. Epub 2017 Oct 30.
4
A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis.
Arthritis Res Ther. 2016 Jun 10;18(1):135. doi: 10.1186/s13075-016-1020-3.
5
Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach.
PLoS One. 2016 Mar 17;11(3):e0148791. doi: 10.1371/journal.pone.0148791. eCollection 2016.
6
Radiographic quantifications of joint space narrowing progression by computer-based approach using temporal subtraction in rheumatoid wrist.
Br J Radiol. 2016;89(1057):20150403. doi: 10.1259/bjr.20150403. Epub 2015 Oct 20.
7
A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis.
BMC Neurol. 2011 Aug 5;11:97. doi: 10.1186/1471-2377-11-97.
8
Racial disparities in treatment preferences for rheumatoid arthritis.
Med Care. 2009 Mar;47(3):350-5. doi: 10.1097/MLR.0b013e31818af829.
本文引用的文献
1
Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility.
Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii56-60. doi: 10.1136/ard.2007.078360.
2
New therapies for treatment of rheumatoid arthritis.
Lancet. 2007 Dec 1;370(9602):1861-74. doi: 10.1016/S0140-6736(07)60784-3.
3
Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).
Ann Rheum Dis. 2007 Nov;66(11):1443-9. doi: 10.1136/ard.2007.071092. Epub 2007 May 22.
4
Regression to the mean using the disease activity score in eligibility and response criteria for prescribing TNF-alpha inhibitors in adults with rheumatoid arthritis.
Rheumatology (Oxford). 2007 Jul;46(7):1165-7. doi: 10.1093/rheumatology/kem109. Epub 2007 May 7.
5
Rationale and strategies for reevaluating the ACR20.
J Rheumatol. 2007 May;34(5):1184-7.
6
The BeSt way to treat early rheumatoid arthritis?
Ann Intern Med. 2007 Mar 20;146(6):459-60. doi: 10.7326/0003-4819-146-6-200703200-00014.
7
Remission of rheumatoid arthritis: should we care about definitions?
Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-45-51.
8
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
Arthritis Rheum. 2006 Jan;54(1):26-37. doi: 10.1002/art.21519.
9
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Lancet. 2004 Feb 28;363(9410):675-81. doi: 10.1016/S0140-6736(04)15640-7.
10
Treating rheumatoid arthritis early: a window of opportunity?
Arthritis Rheum. 2002 Feb;46(2):283-5. doi: 10.1002/art.10092.
Zotero 插件